Medicare Part B (medical insurance) may cover Rituxan (rituximab) infusions. This is because medical professionals typically administer the medication in a medical setting on an outpatient basis.

LONDON (Reuters) - Lymphoma patients who continue regular infusions of Genentech Inc and Biogen Idec's Rituxan after chemotherapy may live longer than patients who stop, Israeli researchers said on ...

The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some cancers and autoimmune diseases. The treatment, named Ruxience, is approved to treat Non-Hodgkin lymphoma, chronic lymphocytic ...

FDA approved Adcetris, Revlimid, and Rituxan for relapsed/refractory LBCL patients ineligible for auto-HSCT or CAR-T therapy, based on ECHELON-3 trial results. The combination therapy showed ...

Truxima (rituximab-abbs) is a prescription drug used to treat certain blood cancers, rheumatoid arthritis, and other conditions. Truxima can cause side effects that range from mild to serious.

Monjuvi, combined with Revlimid and Rituxan, significantly improves progression-free survival in relapsed/refractory follicular lymphoma, as shown in the inMIND trial. The trial reported a median ...

PRESQUE ISLE, Maine (WAGM) - Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the small joints and ...

Rituxan (rituximab) is a type of antibody therapy (biologic) medication that may be used with or without chemotherapy. It destroys or helps your body destroy blood cells that contain cancer. It’s used ...